These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12164379)
1. Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy. Rousselle C; Clair P; Temsamani J; Scherrmann JM J Drug Target; 2002 Jun; 10(4):309-15. PubMed ID: 12164379 [TBL] [Abstract][Full Text] [Related]
2. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. Rousselle C; Smirnova M; Clair P; Lefauconnier JM; Chavanieu A; Calas B; Scherrmann JM; Temsamani J J Pharmacol Exp Ther; 2001 Jan; 296(1):124-31. PubMed ID: 11123372 [TBL] [Abstract][Full Text] [Related]
3. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Rousselle C; Clair P; Lefauconnier JM; Kaczorek M; Scherrmann JM; Temsamani J Mol Pharmacol; 2000 Apr; 57(4):679-86. PubMed ID: 10727512 [TBL] [Abstract][Full Text] [Related]
4. Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy. Rousselle C; Clair P; Smirnova M; Kolesnikov Y; Pasternak GW; Gac-Breton S; Rees AR; Scherrmann JM; Temsamani J J Pharmacol Exp Ther; 2003 Jul; 306(1):371-6. PubMed ID: 12682214 [TBL] [Abstract][Full Text] [Related]
5. Identification and design of peptides as a new drug delivery system for the brain. Demeule M; Régina A; Ché C; Poirier J; Nguyen T; Gabathuler R; Castaigne JP; Béliveau R J Pharmacol Exp Ther; 2008 Mar; 324(3):1064-72. PubMed ID: 18156463 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system. Wu D; Song BW; Vinters HV; Pardridge WM J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825 [TBL] [Abstract][Full Text] [Related]
7. The design and delivery of a PKA inhibitory polypeptide to treat SCA1. Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ J Neurochem; 2014 Oct; 131(1):101-14. PubMed ID: 24903464 [TBL] [Abstract][Full Text] [Related]
8. Delivery of peptides and proteins through the blood-brain barrier. Bickel U; Yoshikawa T; Pardridge WM Adv Drug Deliv Rev; 2001 Mar; 46(1-3):247-79. PubMed ID: 11259843 [TBL] [Abstract][Full Text] [Related]
9. Transport of the beta-lactam antibiotic benzylpenicillin and the dipeptide glycylsarcosine by brain capillary endothelial cells in vitro. Török M; Huwyler J; Drewe J; Gutmann H; Fricker G Drug Metab Dispos; 1998 Nov; 26(11):1144-8. PubMed ID: 9806958 [TBL] [Abstract][Full Text] [Related]
10. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex. Saito Y; Buciak J; Yang J; Pardridge WM Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757 [TBL] [Abstract][Full Text] [Related]
11. [Strategies for drug delivery to the brain across the blood-brain barrier]. Tsuji A Nihon Rinsho; 1998 Mar; 56(3):613-8. PubMed ID: 9549345 [TBL] [Abstract][Full Text] [Related]
12. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system. Wu D; Pardridge WM J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978 [TBL] [Abstract][Full Text] [Related]
13. Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier. Kikuchi R; Kusuhara H; Sugiyama D; Sugiyama Y J Pharmacol Exp Ther; 2003 Jul; 306(1):51-8. PubMed ID: 12684544 [TBL] [Abstract][Full Text] [Related]
14. Facilitated transport of benzylpenicillin through the blood-brain barrier in rats. Suzuki H; Sawada Y; Sugiyama Y; Iga T; Hanano M J Pharmacobiodyn; 1989 Mar; 12(3):182-5. PubMed ID: 2760797 [TBL] [Abstract][Full Text] [Related]
15. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pardridge WM; Wu D; Sakane T Pharm Res; 1998 Apr; 15(4):576-82. PubMed ID: 9587954 [TBL] [Abstract][Full Text] [Related]
16. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study. Aryal M; Vykhodtseva N; Zhang YZ; McDannold N J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272 [TBL] [Abstract][Full Text] [Related]
17. Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats. Wu WM; Pop E; Shek E; Bodor N J Med Chem; 1989 Aug; 32(8):1782-8. PubMed ID: 2754705 [TBL] [Abstract][Full Text] [Related]
18. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system. Wang Z; Zhao Y; Jiang Y; Lv W; Wu L; Wang B; Lv L; Xu Q; Xin H Sci Rep; 2015 Jul; 5():12651. PubMed ID: 26219474 [TBL] [Abstract][Full Text] [Related]
19. Recent developments in peptide drug delivery to the brain. Pardridge WM Pharmacol Toxicol; 1992 Jul; 71(1):3-10. PubMed ID: 1523192 [TBL] [Abstract][Full Text] [Related]
20. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]